Abstract
This chapter describes this novel device and reviews its current status, indications, and use. At the time of publication, KeraKlear KPro has received CE mark approval in Europe but has not yet been approved by the US Food and Drug Administration (FDA) for use in the United States (John et al., Ocular Surg News 30(16):5–6, 2012).
Cite
CITATION STYLE
APA
Pineda, R. (2015). The keraklear artificial cornea. In Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications (pp. 213–219). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-55179-6_23
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free